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Introduction: Epilepsy represents an important public health issue, in particular in low
andmiddle-income countries where significant disparities are present in the care available
for patients with epilepsy. Treatment cost and unavailability of drugs represent important
barriers in treating people with epilepsy especially in rural setting. Aim of the study was
to evaluate, by means of routine data, the current real-life clinical practice in epilepsy
in the rural communities of the Plurinational State of Bolivia. Treatment activity followed
educational campaigns and an anthropological fieldwork over more than 20 years.
Material and Methods: Medical records of people with epilepsy (PWE) living in the
rural communities of the Bolivian Chaco who received antiepileptic drugs (AEDs), from
2012 to 2016, and were followed-up for at least 1 year were analyzed. Treatment delivery
and follow up visits were managed by a neurologist with the support of rural health care
workers.
Results: From 2012 to 2016, 157 PWE (76 men with a mean age of 24.2 ± 15.7) have
been included in the study. Structural epilepsy was the most common type, recorded
in 54 cases (34.4%) and the most common reported causes were perinatal factors,
present in 11 subjects (20.0%). Almost all patients presented epilepsy with generalized
tonic-clonic seizures (91.4%). The most common AED prescribed was phenobarbital
followed by carbamazepine. During the follow-up, a dramatic seizures reduction was
observed, with 31 subjects (19.7%) being seizures-free at the last follow-up. However,
48 subjects (30.6%) did not assume the medication regularly and 10 interrupted the drug
intake. More than 20% of PWE did not receive any financial supports for AEDs. During
the follow-up period 10 patients died but only in one case the death was probably caused
by epilepsy.
Nicoletti et al. Treating Epilepsy in Low-Income Countries
Conclusion: Our study demonstrated that PWE in rural areas of the Bolivian Chaco
are willing to seek medical attention and to receive antiepileptic treatment. However,
improvement in care is needed to assure compliance to AED treatment, including activity
to increase awareness toward epilepsy among community members and health staff of
the rural communities and to guarantee the coverage of treatment costs and drug supply.
Keywords: epilepsy, treatment, low-income countries, management, real-life
INTRODUCTION
Throughout the world, epilepsy represents an important public
health issue, accounting for an estimated 0.7% of the global
burden of diseases. It affects approximately 70 million people
worldwide of whom the majority live in low and middle-
income countries (LMIC) (1). In particular, about 5 million
people living in Latin American Countries (LAC) are affected
by epilepsy (2). In the Chaco region, which is part of the
Plurinational State of Bolivia, it was found a prevalence of lifetime
epilepsy of 12.3/1,000 and a prevalence of active epilepsy of
11.1/1,000. In a recent study the life-time prevalence of epilepsy
associated with generalized tonic-clonic seizures (GTCS) was
found to be 7.2/1,000 and the prevalence of its active form
6.6/1,000 with a crude incidence risk of 55.4/100,000 in the
same area (3–5). According to a recent meta-analysis in Latin
American countries the treatment gap (TG) is 60.6% (95% CI
45.3–74.9), with high differences between rural (77.8%; 95%
CI 67.4–86.8) and urban (26.2%; 95% CI 10.2–46.4) areas (5).
In LMIC there are significant disparities in the care available
for patients with epilepsy (PWE). Most neurologists work in
the urban private sector, where the level of care is similar
to that found in developed countries. However, in the poorer
urban and rural areas this level of care is rarely available (6).
In this latter setting, indeed, general practitioners (GPs) have
an important role in providing care and support to PWE.
However, in rural areas non-medical health workers such as
nurses and community health workers (CHWs) are often the
only health care staff present who can diagnose epilepsy with
GTCS. As pointed out by recent WHO recommendations, in
LMIC settings epilepsy with GTCS, should be recognized and
treated at primary care level by trained non-specialist health care
providers (7).
Thus, education of primary health workers and other
clinicians working in the rural areas represents a key action
in the reduction of the treatment gap. Nonetheless treatment
cost and unavailability of drugs represent a further important
barrier in treating PWE in rural setting (6). Consequently,
specific programs for the improvement of knowledge and
awareness about epilepsy in these settings are not sufficient if
not accompanied by governmental actions aimed to support the
treatment cost and drug supply. The reduction of epilepsy TG
in the area of Chaco has been the main aim of many different
projects performed by our group over the last 20 years in this area
(3, 4, 8–12). However, even if a reduction of TG was recorded
over the time by the subsequent studies carried-out (3, 4, 13),
the real impact of our activity in the clinical practice of PWE has
never been evaluated until now.
Aim of the present study was to evaluate, by means of routine
data coming from the rural communities of the Bolivian Chaco,
the current real-life clinical practice in epilepsy in the rural
communities of the Plurinational State of Bolivia.
MATERIALS AND METHODS
Study Area
The study has been conducted in the Chaco area of the
Plurinational State of Bolivia, which is a low-middle income
country where about 4 million people live under the “poverty
line” (14). In particular in rural areas the access to the
health system is still difficult (15). However, a slight economic
improvement has been recorded in the last few years, since
the approval of the 2016-2020 National Economic and Social
Development Plan by the Government of Bolivia aimed at
maintaining growth of 5% and reducing poverty (16, 17). Indeed,
with the application of policies to improve the economy, the
social and health services and thanks to specific programs
such as Bono Juana Azurduy, Programa Mi Salud, Ley de
Gratuidad, Seguros departamentales, there was an increase in
the social security and an improvement of the Bolivian health
system (18).
PWE involved in this study come from three Departments
of the Plurinatinal State of Bolivia: the Department of Santa
Cruz (municipalities of Boyuibe, Cabezas, Cuevo, Lagunillas,
Gutierrez, Eiti, Camiri and S. Antonio Parapetí), the Department
of Chuquisaca (municipalities of Macharetí and Muyupampa or
Villa Vaca Guzmán) and the Department of Tarija (municipality
of Villamontes). These Departments are part of the Chaco
region (Figure 1), that is a subtropical area, inhabited mainly
by indigenous Guaraní people. They live in communities
that often lack basic services such as running water or
electricity, basing their economy on animal husbandry and
agriculture.
Study Population
About 190,000 people live in the Bolivian Chaco and among
them about 80,000 are indigenous Guarani. It is estimated
that 49% of the population live in rural areas with 68.9%
of the population living in conditions of poverty, the
majority of them still presenting unresolved issues such as
energy and sanitation supplies1. In the last 25 years, many
1 OPS/OMS Paraguay - Rostros, Voces y Lugares: El Chaco Sudamericano.
Available online at: https://www.paho.org/par/index.php?option=com_docman&
view=document&layout=default&alias=139-rostros-voces-y-lugares-el-chaco-
sudamericano&category_slug=salud-familiar-y-comunitaria&Itemid=253
(Accessed September 4, 2018).
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FIGURE 1 | Map of the Plurinational State of Bolivia with highlighted on the top left the area of the Chaco region and the three departments of Santa Cruz,
Chuquisaca and Tarija.
activities aimed at improving knowledge about epilepsy
and reducing TG have been conducted by our group in
the rural communities of the Chaco region. (8–14). After
the assessment of the prevalence, incidence, mortality and
the most frequent causes of epilepsy, the evaluation of the
sociocultural dimension of epilepsy and epilepsy-associated
stigma among members of the Guaraní communities, many
training courses about epilepsy have been organized directed
to the health staff and all the members of the communities
(3, 4, 8–13, 19). In particular an educational campaign
directed to GPs and non-medical health staff has recently
been implemented with teaching courses regarding the main
causes of epilepsy, epilepsy diagnosis and treatments, first
aid, prevention of the secondary forms of epilepsy and
psychosocial aspects such as social stigma and discrimination
(10, 19).
From 2012 to 2016 a Bolivian neurologist, working in
Santa Cruz, participated to the teaching activity, organized in
collaboration with the “Convenio de Salud” and the “Escuela
Tekove Katu.” The “Convenio de Salud,” located in Camiri,
works through cooperation projects with the University of
Florence in Italy and the Pan American Health Organization. Its
objective is to improve the health conditions of the indigenous
Guaraní population through the development of health projects
in primary care. The “Tekove Katu” school, located in Gutierrez,
carries out training courses since 1985 and is an integral part
of the educational and health system of the Plurinational State
of Bolivia2. The neurologist guaranteed a bimonthly service of
neurological visits to PWE living in the rural communities of the
Chaco region.
Subjects identified by trained nurses or CHWs, as well as
PWE already diagnosed by the GPs working in the rural areas
or identified during the different epidemiological surveys, were
attended in the main health centers located in the different areas.
When the diagnosis of epilepsy was confirmed, AEDs were
prescribed and for PWE already in AED treatment, prescription
was confirmed according to the neurologist’s judgement.
This clinical activity was not part of a specific scientific
programme and clinical data were routinely collected without
the aim to be analyzed. Consequently, due to the lack of a
standardized data collection, often incomplete information was
gathered with a certain amount of missing data.
All medical records of all PWE coming from rural
communities who received AEDs treatment and were followed-
up for at least 1 year were analyzed by two independent observers
(LG, CEC). Those patients for whom not sufficient information
was available or who underwent only one neurological visit
without follow-up have been excluded (Figure 2).
Diagnosis of epilepsy was generally performed just on the
bases of the clinical history because the majority of cases never
underwent EEG recording or neuroimages. On the bases of
2Home - Scuola di Salute Pubblica Tekove Katu. Available online at: http://www.
tekovekatu.org/ (Accessed January 30, 2018).
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FIGURE 2 | Flow chart describing the study population. AEDs, antiepileptic drugs; PWE, people with epilepsy.
the clinical history, epilepsy was defined according to the ILAE
definition and classification proposed in 2017 (20). In particular,
according to the causes, epilepsy was classified as “structural”
when an imaging abnormality was the likely cause of the patient’s
seizures; “genetic generalized” when an idiopathic form with a
genetic predisposition was suspected on the bases of the clinical
history; “of unknown etiology” when the cause of the epilepsy
was not yet known; “unknown” when there was not adequate
information to classify epilepsy type into a category (20).
Among the causes of structural epilepsy, perinatal factors
were defined when there was an evidence of a hypoxic-ischemic
encephalopathy (21); traumatic brain injury was defined as an
insult to the brain from an external mechanical force, with an
associated diminished or altered state of consciousness (22);
neurocysticercosis (NCC) was defined according the most recent
criteria (23); for the other possible causes we based our diagnosis
on the previous clinical report.
Data Management and Statistical Analysis
Medical records were revised twice by two different operators
(CC, LG) and relevant data were collected in an ad hoc
created standardized form. Data were double entered into the
database and statistical analysis was performed using the software
STATA 12 (version 12.0, College Station, TX). Data cleaning
was performed before the data analysis considering range and
consistency checks. Quantitative variables were described as
mean and standard deviation (SD) while frequencies using
percentages. The frequency comparisons were performed using
the chi-squared test.
Ethical Approval
The study has been approved by the Ethical committee of the
Bolivian Neurological Society.
RESULTS
From 2012 to 2016, 215 PWE from the rural communities of
the Gran Chaco area underwent a neurological examination and
received at least an AED prescription. Of these, 18 were excluded
from the analysis because no sufficient information was available,
while 40 were excluded due to the lack of a follow-up visit. Finally,
157 PWE (76 men with a mean age of 24.2 ± 15.7) who had had
at least 1 year of follow up were included in the analysis. The
majority of them came from the areas of Camiri, Gutierrez and
Eiti as shown in Table 1. Baseline characteristics are shown in
Table 1.
The mean age at epilepsy onset was 9.6 ± 12.2. Seizure
types were classified on the bases of the clinical history which
was available in 113 cases (72%). Almost all patients presented
epilepsy with GTCS of whom 26 (23.0%) focal to bilateral tonic-
clonic seizures, while 81 (71.7%) were classified as generalized
tonic-clonic. Only 6 (5.3%) presented focal seizures (Table 2).
Structural epilepsy was the most common type of epilepsy,
recorded in 54 cases (34.4%) followed by epilepsy of unknown
etiology (22 cases, 14.0%) and genetic generalized epilepsy (21,
13.4%). Nonetheless, for 60 cases (38.2%) epilepsy was defined as
unknown (Table 2).
Concerning the causes of structural epilepsy, perinatal factors
were the most commonly reported, being present in 11 subjects
(20.4%), followed by head trauma (11.1%). A diagnosis of
meningitis was reported in 5 cases, NCC in 3 while other
structural causes such as stroke or cysts were reported in 6 cases.
For 22 cases (14.0%) “known” causes were not reported and
were then classified as epilepsy of unknown etiology. Clinical
characteristics of epilepsy are shown in Table 2.
Presence of co-morbidities was reported in 24 cases (15.3%)
and the majority (17 subjects; 10.8%) presented developmental
delay; however, for 22 cases this information was missing.
Overall, themost commonAED prescribed was phenobarbital
followed by carbamazepine and by the association of
phenobarbital and carbamazepine. AEDs treatment during
the follow-up period (2012–2016) is reported in Figure 3.
Information about seizure frequency before and after the
treatment were available only for 47 patients. Before the AEDs
treatment only 13% of cases presented sporadic seizures (2–3
per year) while the majority (55%) presented monthly or weekly
seizures and 32% reported to have seizures every day. During
the follow-up, a dramatic seizures reduction was observed and,
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TABLE 1 | Demographic features of the patients.
N = 157 (%)
Sex (M) 76 (48.4)
Mean age 24.2 ± 15.7
Mean age at
onset
9.6 ± 12.2
OCCUPATION
Unemployed 30 (19.1)
Student 39 (24.8)
Housewife 29 (18.5)
Farmer 15 (9.5)
Other 10 (6.4)
Not known 34 (21.7)
AREA OF ORIGIN
Boyuibe 12 (7.6)
Cabezas 13 (8.3)
Camiri 45 (28.7)
Cuevo 4 (2.5)
Eiti 30 (19.1)
Gutierrez 25 (15.9)
Lagunillas 9 (5.7)
Macharetí 9 (5.7)
Muyupampa 2 (1.3)
San Antonio
Parapetí
8 (5.1)
N, number; M, men.
TABLE 2 | Classification and causes of epilepsy.
N (%)
CLASSIFICATION OF EPILEPSY
Focal epilepsy 76 (48.4)
Generalized epilepsy 21 (13.4)
Unknown epilepsy 60 (38.2)
CLASSIFICATION OF EPILEPSY BASED ON THE ETIOLOGY
Structural epilepsy 54 (34.4)
Genetic generalized epilepsy 21 (13.4)
Epilepsy of unknown etiology 22 (14.0)
Unknown epilepsy 60 (38.2)
CLASSIFICATION OF SEIZURES (N = 113)
Focal 6 (5.3)
Focal to bilateral tonic-clonic 26 (23.0)
Generalized tonic-clonic 81 (71.7)
N, number.
in particular, 14/47 (30%) were seizure-free during the last year
of follow-up, while 19% presented only sporadic seizures, and
most of them just when they did not take the AEDs regularly.
Frequency of seizures before and after treatment for these
patients is reported in Figure 4. Of 157 PWE, 31 (19.7) were
seizure-free at the last follow-up.
It should be underlined that 48 subjects (30.6%) stated to not
assume regularly the medication and that 10 (6.4%) interrupted
the drug intake. Of these, 8 (13.8%) interrupted AED treatment
due to the absence of seizures, while for the others the most
common reason for an irregular intake or interruption was
the lack of medication, in part due to economic reasons. The
cost of AEDs, in fact, was covered by the Ministry of Health
programmes (Mi Salud and Seguro Universal Materno Infantil,
SUMI) or by the municipality (“alcaldia”) for 21 (13.4%) patients,
by the local Strategic Partner Organizations (SPOs) of the Non-
governmental Organization (NGO) “Liliane Fonds” (20.4%) and
by the Convenio de Salud (11.5%). At any rate, more than 20% of
PWE did not receive any financial supports.
During the follow-up period, 10 (6.4%), of the 157 PWE, died.
Of them, 9 died due to causes not directly related to seizures,
while only in one case a seizure-related cause was identified.
In particular, the causes of death were the followings: severe
malnutrition in four cases, malnutrition and pneumonia in two
cases, pneumonia in one case, alcohol addiction complications
in two cases, severe burn following a fall during a seizure in
another case. Five of the 10 subjects suffered from structural
epilepsy and six (60%) had also other comorbidities. Among
these subjects, three had suspended the treatment, while five
declared an irregular intake. The patient for whom a seizure-
related death has been suspected was suffering from epilepsy
with GTCS and alcoholism and he had suspended his treatment
because of alcohol abuse.
DISCUSSION
Epilepsy treatment gap is an important public health problem
in LMICs and in particular in the rural areas. Inadequate
trained staff, cost of antiepileptic treatment and its unavailability,
cultural misbeliefs about epilepsy, use of traditional medicine,
and distance from the health posts represent its main causes (6)
and appropriate interventions have been suggested to reduce it
(24).
Among the suggested interventions, the core actions are
represented by training nurses and community health workers,
in order to be able to identify people with epilepsy, and training
GPs working in the rural communities in order to diagnose and
initiate epilepsy treatment (10). Indeed, according to the WHO
guidelines, in LMICs settings epilepsy with GTCS should be
diagnosed at primary care level by trained non-specialist health
care providers (7). Moreover, increasing communities’ awareness
about epilepsy represents a further important action in order
to reduce stigma and improve the adherence to the epilepsy
treatment, even if misconceptions about epilepsy and recourse to
traditional healers are challenging to change.
During our long-lasting activity in rural Bolivia, in agreement
with the ILAE and WHO recommendations, from 1994 up to
date we performed several epidemiological and interventional
surveys including an anthropological survey, training programs
directed to GPs, nurses and CHWs of the rural communities of
the Chaco region as well as communities awareness programs
(ongoing activity). Training activities were mainly directed to
the Knowledge, Attitudes and Practice (KAP) and management
of epilepsy with GTCS. The activities conducted by our group
during these last 25 years, have surely increased the level
of knowledge and awareness about epilepsy in this region as
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FIGURE 3 | Percentage of subjects treated with different AEDs per year. CBZ, carbamazepine; PB, phenobarbital; VPA, valproic acid; PHT, phenytoin.
FIGURE 4 | Frequency of seizures before and after treatment in 47 patients with epilepsy.
demonstrated by the drop in the level of treatment gap recorded
during different epidemiological survey over the time. Indeed, in
our first survey performed in 1994 a treatment gap of about 90%
was recorded while in 2010 a reduction of TG to values of about
70% has been found; finally in 2016 a value of TG of 45% has been
recorded (3, 4, 13).
Although recognizing the importance of data coming from
well-designed epidemiological studies, we believe that it can be
worthwhile to evaluate the impact of our activity on the “real
life” and not only under experimental conditions. Several trials
have already demonstrated the feasibility of the treatment of
epilepsy with GTCS under experimental conditions (25), but
few data are available regarding the following step, namely the
clinical practice in these settings. In experimental conditions, in
fact, PWE are strictly monitored, the treatment is guaranteed
and often delivered directly in the communities; furthermore,
sometimes the costs of the AEDs have been directly covered by
the project. However, what happens after the trial? Which is
the real adherence to the treatment and the risk of an abrupt
interruption? Which are the main causes of an irregular intake?
All these important questions can be addressed only by the
analysis of routine data, taking into account all the limits related
to this kind of study. In fact, routine data collected for the clinical
practice have the fault of lacking information with possible
missing data for many subjects and many variables. Moreover,
we are absolutely aware about the possible selection bias related
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to the fact that PWE treated and included in the analysis can
have different characteristics with respect to those never treated.
Nonetheless, from our point of view, despite all the possible
limits, important food for thought comes from this study.
As expected on the bases of our activities that, in agreement
with theWHO guidelines, have been focused on themanagement
of GTCS, more than 90% of PWE on treatment presented
convulsive epilepsy. Concerning the epilepsy causes, it was
possible to define the epilepsy type only in a minority of cases,
since in 14% of cases epilepsy was defined as of unknown etiology
and in 38.2% of patients, epilepsy diagnosis was not possible.
This high level of diagnostic uncertainty, with consequent
underestimation of the most frequent recognized epilepsy causes,
such as NCC (11), is certainly due to the low availability of
reliable diagnostic tools in these areas. Treating epilepsy with
GTCS in rural communities, regardless of its causes, is feasible
as demonstrated by the high frequency of a regular intake and
the dramatic seizures reduction. Nonetheless 30% of subjects
reported an irregular intake often due to irregular AEDs supply
and economic reasons. On the other hand, AEDs adherence
does not seem to be influenced by stigma or cultural beliefs.
Thus, whenwe increase knowledge and awareness about epilepsy,
the treatment is well accepted and sought by PWE. However,
cost and supply still represent an important barrier in these
areas. Currently, the costs of AEDs are in part covered by
NGOs or other non-governmental institutions. An effort should
be made to extend the cost coverage of AEDs by national
and departmental health institutions since the cost of the most
common AEDs used in Bolivia is very low. In fact, considering
the most common drugs used, the annual cost of a treatment
with the average dosage used of 100mg of PB daily would be
only about 50 $ per person a year, as well as the annual treatment
with 400mg of CBZ, which would cost about 95 $ per person
a year. Only 21.6% of cases are currently taken in charge by
the municipality and Ministry of Health (Mi Salud and SUMI).
Furthermore, the follow-up depends entirely by the volunteer
action of local neurologists. It should be underlined that even
if the follow-up can be performed by the GPs working in the
rural area, in Bolivia, as well as in other countries, phenobarbital,
that represents the first line drug, can be prescribed only by
neurologists. In this perspective, the presence of a neurologist
should be considered as an essential element within a team
attending PWE, acting as prescriber and reference specialist for
GPs. Programs should consider this presence and the relative
costs.
Mortality rate for epilepsy in the Chaco area was 10/1,000
(12) and even if, due to the different study design, a direct
comparison cannot be made, the number of deaths recorded
in this sample (10 out of 157 PWE) is probably higher than
expected. As already reported it is possible that patients seeking
treatment and consequently included in the study were the most
severe ones, thus leading to a possible selection bias. Indeed,
patients who died were affected by more severe forms of disease
as demonstrated by a high rate of comorbidities present in 60% of
subjects, mainly represented by developmental delay. Moreover,
all patients presented a structural epilepsy with only GTCS and
with a frequency higher with respect to the rest of the sample
(57.15% with weekly or daily seizures before treatment). In
agreement with this observation, nine patients died due to causes
not directly related to seizures, such as severe malnutrition,
pneumonia and alcohol addiction, while only in one case a
seizure-related cause was identified (severe burn following a fall
during a seizure). Nonetheless, this latter patient interrupted his
treatment intake because of alcohol abuse.
We are aware that our study includes only a part of
PWE residing in this area. Indeed, considering the total rural
population of the study areas (about 75,000 inhabitants according
to the 2012 census) and according to the prevalence of active
epilepsy associated with GTCS (6.6/1,000) (4) which is the most
common type, about 495 PWE are expected in this population.
Thus, we can conclude that about 50% of PWE (n= 215) received
medical attention and were treated with an AED in this area,
percentage that is roughly close to the last TG recorded in the
same area (13). Nonetheless, this is not a population survey
and, as reported, selection bias is probable. It is possible to
hypothesize, in fact, that PWE affected bymore severe forms were
more prone to seek medical attention and treatment. To these
reasons, our data do not allow to reach any conclusion regarding
the effective TG. According to our experience, after improving
knowledge and awareness in the rural population, PWE are
willing to seek medical attention and to receive antiepileptic
treatment, and these considerations can be extended to other
similar settings.
At this point governmental and departmental actions are
urgently needed in order to guarantee an adequate treatment
and medical attention in these areas. In particular, local
government should strengthen specific training programs for
the GPs and CHWs living in the rural area and should support
supply of generic, low-cost, first-line AEDs. These actions could
lead to a significant improvement of epilepsy care in rural
areas.
Furthermore, the national organizations and international
official epilepsy institutions should reinforce their actions in
order to obtain equal conditions people with epilepsy in the
different parts of the world.
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